Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Scandinavian Journal of Infectious Diseases
|
July 16, 2013
Risk factors for catheter-related bloodstream infections in adult hospitalized patients - multicenter cohort study
Yoshio Haga, Nobutomo Miyanari, Tadateru Takahashi, et al.
Clinical Case Reports
|
January 1, 2024
Urinary tract infection associated with bacteremia caused by vancomycin-resistant enterococcus following continent urinary diversion
Kai Morishita, Soichiro Kashiwabara, Yuki Matsumoto, et al.
International Journal of Clinical Oncology
|
May 4, 2012
Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer
Osamu Ishizuka, Osamu Nishizawa, Shuji Nishizawa, et al.
International Journal of Clinical Oncology
|
November 23, 2020
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial
Hiroji Uemura, Hisashi Matsushima, Kazuki Kobayashi, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Scandinavian Journal of Infectious Diseases
|
July 16, 2013
Risk factors for catheter-related bloodstream infections in adult hospitalized patients - multicenter cohort study
Yoshio Haga, Nobutomo Miyanari, Tadateru Takahashi, et al.
Clinical Case Reports
|
January 1, 2024
Urinary tract infection associated with bacteremia caused by vancomycin-resistant enterococcus following continent urinary diversion
Kai Morishita, Soichiro Kashiwabara, Yuki Matsumoto, et al.
International Journal of Clinical Oncology
|
May 4, 2012
Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer
Osamu Ishizuka, Osamu Nishizawa, Shuji Nishizawa, et al.
International Journal of Clinical Oncology
|
November 23, 2020
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial
Hiroji Uemura, Hisashi Matsushima, Kazuki Kobayashi, et al.
Page
of 3